Press release
Nonalcoholic Steatohepatitis Market is Considered as One of the Rapidly Growing market by 2021
Nonalcoholic Steatohepatitis Market
Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. It is also known as silent liver disease. It is a type of nonalcoholic fatty liver disease (NAFLD), which mainly affects people with diabetes and obesity. Nonalcoholic Steatohepatitis (NASH) is defined by histological hallmarks of inflammation, hepatic steatosis, cell death, and fibrosis. A number of drugs used to treat medical situation have been NASH, such as amiodarone (Corderone, Pacerone), tamoxifen (Nolvadex), perhexiline maleate (Pexhid) and steroids (eg, prednisone). Medical studies have identified a strong connection of NASH with certain risk factors such as insulin resistance, oxidative stress and release of toxic inflammatory proteins.
Nonalcoholic steatohepatitis is a gradually becoming common chronic liver disease around the world and is closely related with diabetes and obesity. Rising incidence of NAFLD cases, changing lifestyle patterns, increasing rate of obesity and diabetes, and initiatives for research and development are the major driving factors of this market. However, insufficient information about the pathophysiology of NASH tissue and ineffective diagnostic technology for NASH is considered to restraint in this market.
Browse the full report at: http://www.syndicatemarketresearch.com/market-analysis/nonalcoholic-steatohepatitis-market.html
The report includes detailed competitive landscape of the global nonalcoholic steatohepatitis market and an analysis of Porter’s five forces model for the nonalcoholic steatohepatitis market has also been included. It includes company market share analysis, product portfolio of the major industry participants. The report provides detailed segmentation of the nonalcoholic steatohepatitis market based on drugs type and region segment. GFT505, Obeticholic Acid (INT-747), Simtuzumab and Liraglutide (Victoza), Vitamin E, Poglitazone, Placebo is the drug type segment of nonalcoholic steatohepatitis market.
Major regional segments analyzed in this study include North America, Europe, Asia Pacific, Latin America, and Middle East and Africa with its further bifurcation into major countries including U.S., Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for nonalcoholic steatohepatitis based on individual products and applications in all the regions and countries. The nonalcoholic steatohepatitis market is dominated by North America followed by Asia Pacific. Asia pacific is expected to the fastest growing segment in the forecast period.
Get Sample Research Report at : http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=52719
Nonalcoholic Steatohepatitis Market: Key Players
The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. Key players profiled in the report include Intercepts Pharmaceuticals, Exalenz Bioscience Inc., Galectin Therapeutics Inc., Genfit, Gilead Science, AstraZeneca plc, Echosense SA, Raptor Pharmaceutical Corp, Matinas Biopharma Holdings Inc., Enzo Biochem, Inc., Galmed Pharmaceuticals Ltd., Perspectum Diagnostics and Novo Nordisk.
This report segments the global nonalcoholic steatohepatitis market as follows:
Global Nonalcoholic Steatohepatitis Market: Drug Type Segment Analysis
GFT505
Obeticholic Acid (INT-747)
Simtuzumab and Liraglutide (Victoza)
Vitamin E
Poglitazone
Placebo
Global Nonalcoholic Steatohepatitis Market: Regional Segment Analysis
North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East And Africa
About Us
Syndicate Market Research provides a range of marketing and business research solutions designed for our client’s specific needs based on our expert resources. The business scopes of Syndicate Market Research cover more than 30 industries includsing energy, new materials, transportation, daily consumer goods, chemicals, etc. We provide our clients with one-stop solution for all the research requirements.
Contact US:
Joel John
3422 SW 15 Street,Suit #8138
Deerfield Beach,Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803
Email: sales@syndicatemarketresearch.com
Website: http://www.syndicatemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nonalcoholic Steatohepatitis Market is Considered as One of the Rapidly Growing market by 2021 here
News-ID: 451408 • Views: …
More Releases from Syndicate Market Research
Copper Foil Market to Surpass USD 9.87 Billion by 2030 | Rising Demand for Aesth …
According to the report published by Zion Market Research, the global Copper Foil Market size was valued at USD 5.31 Billion in 2022 and is predicted to reach USD 19.17 Billion by the end of 2030. The market is expected to grow with a CAGR of 7.01% during the forecast period. The report analyzes the global Foldable And Collapsible Pallets Market's growth drivers, restraints, and impact on demand during the…
Global Light Rail Vehicle Market Analysis by Size, Share, Key Drivers, Growth Op …
"A SWOT Analysis of Light Rail Vehicle, Professional Survey Report Including Top Most Global Players Analysis with CAGR and Stock Market Up and Down."
Click here to access the report : https://www.syndicatemarketresearch.com/sample/light-rail-vehicle-market
The global "Light Rail Vehicle market" research report portrays a deep analysis of the global Light Rail Vehicle market. The market value is calculated by analyzing the revenue (USD Million) and size (k.MT) of the global Light Rail Vehicle market.…
Global High-mounted Stop Lamps Market Analysis, Revenue, Size, Price, Market Sha …
"A SWOT Analysis of High-mounted Stop Lamps, Professional Survey Report Including Top Most Global Players Analysis with CAGR and Stock Market Up and Down."
Click here to access the report : https://www.syndicatemarketresearch.com/sample/high-mounted-stop-lamps-market
The global "High-mounted Stop Lamps market" research report portrays a deep analysis of the global High-mounted Stop Lamps market. The market value is calculated by analyzing the revenue (USD Million) and size (k.MT) of the global High-mounted Stop Lamps market.…
Global Wiper Blade Market size,Share, Leading Players, Growth, Development and D …
"A SWOT Analysis of Wiper Blade, Professional Survey Report Including Top Most Global Players Analysis with CAGR and Stock Market Up and Down."
Apply here for the FREE sample copy of the report @: https://www.syndicatemarketresearch.com/sample/wiper-blade-market
The "Wiper Blade Market" research report presents an all-inclusive study of the global Wiper Blade market. The report includes all the major trends and technologies performing a major role in the Wiper Blade market development during forecast…
More Releases for Nonalcoholic
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Drinking Nonalcoholic Beer Market Size 2024 to 2031.
Market Overview and Report Coverage
Drinking nonalcoholic beer is a type of beverage that has gained popularity as a healthier alternative to traditional beer. It contains little to no alcohol, making it suitable for individuals looking to enjoy the taste of beer without the effects of alcohol. The market for drinking nonalcoholic beer is steadily growing, with a projected CAGR of 6.00% during the forecasted period.
The future outlook of…
Nonalcoholic Steatohepatitis Treatment Market Analysis
As per the research conducted by GME, the Global Nonalcoholic Steatohepatitis Treatment Market will grow with a CAGR value of 39.1% by 2026. Over the forecast era, the production of NASH biomarkers is expected to be aided by increasing demand for non-invasive diagnostic tools and increased patient awareness. The low use of invasive procedures for disease diagnosis is due to the high cost of liver biopsy, its invasiveness, and patients'…
Nonalcoholic Steatohepatitis Therapeutics Market - Current status and future tre …
The global nonalcoholic steatohepatitis therapeutics market is dominated by companies such as Intercept Pharmaceuticals Inc., GENFIT SA, Galmed Pharmaceuticals Ltd., Zydus Cadila, AstraZeneca plc., Gilead Sciences, Inc., and Immuron Ltd. Key companies are focusing on the introduction of new drugs and therapeutics to treat nonalcoholic steatohepatitis (NASH). As per the Natural Medical Journal, the occurrence of nonalcoholic fatty liver diseases is expected to increase in the U.S., which is likely…
Emerging Opportunities in Nonalcoholic Steatohepatitis Therapeutics Market
Global Nonalcoholic Steatohepatitis (NASH) Market: Snapshot
Nonalcoholic Steatohepatitis (NASH), a syndrome found in non-alcoholic patients, causes damage to liver that is histologically akin to alcoholic hepatitis. NASH results from fat in the liver, along with inflammation. Symptoms in NASH usually do not show, but it can be severe and lead to cirrhosis, which is permanent damage to the liver.
Those suffering from obesity, dyslipidemia, and glucose intolerance are most likely…
Global Nonalcoholic Steatohepatitis Therapeutics Market
Nonalcoholic Steatohepatitis (NASH), also called the ‘silent disease,’ is a kind of fatty liver disease which typically affects people that are obese or diabetic. This disease is more prevalent in the younger generation and causes liver inflammation and/or damage owing to the accumulation of fat within the liver. The exact cause of this disease is still not clear; however, research activities are underway for finding effective treatments to cure this…
